Description
Cell line name NCC-MRT1-C1
Accession CVCL_C4MW
Resource Identification Initiative To cite this cell line use: NCC-MRT1-C1 (RRID:CVCL_C4MW)
Comments Part of: NCC sarcoma cell line panel.
Population: Japanese.
Doubling time: 30 hours (PubMed=35927606).
Omics: SNP array analysis.
Derived from site: In situ; Left thigh, hypodermis; UBERON=UBERON_0000376+UBERON_0002072.
Sequence variations
Gene deletion; HGNC; 11103; SMARCB1; Zygosity=Homozygous (PubMed=35927606).
Disease Extrarenal rhabdoid tumor (NCIt: C6586)
Rhabdoid tumor (ORDO: Orphanet_69077)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Sex of cell Female
Age at sampling 18Y
Category Cancer cell line
STR profile
Source(s): PubMed=35927606
Markers:
Amelogenin | X |
CSF1PO | 11,12 |
D5S818 | 10,11 |
D7S820 | 11 |
D13S317 | 9,12 |
D16S539 | 10,11 |
D21S11 | 31.2,33.2 |
TH01 | 9 |
TPOX | 8,11 |
vWA | 14,19 |
Publications
PubMed=35927606; DOI=10.1007/s13577-022-00751-z
Akiyama T., Yoshimatsu Y., Noguchi R., Sin Y., Tsuchiya R., Ono T., Sato C., Kojima N., Yoshida A., Kawai A., Ohtori S., Kondo T.
Establishment and characterization of NCC-MRT1-C1: a novel cell line of malignant rhabdoid tumor.
Hum. Cell 35:2002-2010(2022)
Cross-references
Encyclopedic resources Wikidata; Q116049880
Reviews
There are no reviews yet.